Seborrheic keratitis flare; Felt lousy; Sore arm; Flu like symptoms; Possible low grade fever; This spontaneous case was reported by a physician and describes the occurrence of DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Possible low grade fever) and SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever). On an unknown date, the patient experienced SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 20-Feb-2021, DISCOMFORT (Felt lousy), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever) had resolved. On 21-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a physician and describes the occurrence of DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Possible low grade fever) and SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever). On an unknown date, the patient experienced SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 20-Feb-2021, DISCOMFORT (Felt lousy), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever) had resolved. On 21-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.